- Home
- UVSP vs KURA Comparison
UVSP vs KURA Comparison
Compare UVSP & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UVSP | KURA |
|---|---|---|
| Founded | 1876 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | UVSP | KURA |
|---|---|---|
| Price | $40.91 | $12.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $36.67 | $25.56 |
| AVG Volume (30 Days) | 178.1K | ★ 2.1M |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | ★ 21.32 | N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $328,056,000.00 | $67,482,000.00 |
| Revenue This Year | $11.65 | $28.28 |
| Revenue Next Year | $4.77 | $106.37 |
| P/E Ratio | $23.09 | ★ N/A |
| Revenue Growth | 9.64 | ★ 25.24 |
| 52 Week Low | $28.04 | $7.36 |
| 52 Week High | $45.46 | $13.90 |
Technical Indicators
Market Signals| Indicator | UVSP | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 31.93 | 63.58 |
| Support Level | $38.50 | $8.07 |
| Resistance Level | $45.40 | $13.90 |
| Average True Range (ATR) | 0.60 | 0.76 |
| MACD | -0.12 | 0.14 |
| Stochastic Oscillator | 2.17 | 74.37 |
Price Performance
Historical ComparisonAbout UVSP Univest Financial Corporation
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.